- Home
- LFUS vs BRKR Comparison
LFUS vs BRKR Comparison
Compare LFUS & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LFUS | BRKR |
|---|---|---|
| Founded | 1927 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | LFUS | BRKR |
|---|---|---|
| Price | $261.26 | $45.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $292.50 | $46.45 |
| AVG Volume (30 Days) | 214.2K | ★ 2.4M |
| Earning Date | 01-27-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.14% | 0.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | $2,321,865,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $10.60 | $3.61 |
| Revenue Next Year | $8.42 | $1.23 |
| P/E Ratio | $55.29 | ★ N/A |
| Revenue Growth | 5.78 | ★ 6.10 |
| 52 Week Low | $142.10 | $28.53 |
| 52 Week High | $275.00 | $64.64 |
Technical Indicators
Market Signals| Indicator | LFUS | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 54.84 | 53.50 |
| Support Level | $252.20 | $44.96 |
| Resistance Level | $274.25 | $47.90 |
| Average True Range (ATR) | 7.44 | 1.85 |
| MACD | 1.42 | -0.57 |
| Stochastic Oscillator | 50.60 | 17.86 |
Price Performance
Historical ComparisonAbout LFUS Littelfuse Inc.
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. The company is also increasing its power semiconductor business, where it predominantly serves industrial end markets, and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.